|
1
|
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
|
Chest
|
2000
|
1.60
|
|
2
|
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
|
JAMA
|
1999
|
1.42
|
|
3
|
Erectile and endothelial dysfunction in Type II diabetes: a possible link.
|
Diabetologia
|
2001
|
1.02
|
|
4
|
Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.87
|
|
5
|
Glucose ingestion affects cardiac ANS in healthy subjects with different amounts of body fat.
|
Am J Physiol
|
1997
|
0.81
|
|
6
|
Association of coagulation factor VArg506Gln mutation with non-insulin-dependent diabetes mellitus.
|
Lancet
|
1996
|
0.81
|
|
7
|
Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer.
|
Exp Oncol
|
2007
|
0.81
|
|
8
|
Resistance to activated protein C in adults with a history of juvenile transient ischemic attacks.
|
Thromb Haemost
|
1996
|
0.79
|
|
9
|
A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing.
|
Blood
|
2000
|
0.79
|
|
10
|
Association of primary antiphospholipid syndrome with inherited activated protein C resistance.
|
J Rheumatol
|
1998
|
0.78
|
|
11
|
ACE gene polymorphism and insulin action in older subjects and healthy centenarians.
|
J Am Geriatr Soc
|
2001
|
0.78
|
|
12
|
[Blood coagulation changes in patients with post-splenectomy persistent thrombocytosis].
|
Chir Ital
|
2001
|
0.78
|
|
13
|
Homozygous prothrombin gene mutation and ischemic cerebrovascular disease: a case report.
|
Acta Haematol
|
1999
|
0.77
|
|
14
|
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
|
Eur J Clin Pharmacol
|
1999
|
0.77
|
|
15
|
[A retrospective study of the serum CEA, AFP, TPA and ferritin values in 500 patients with chronic liver diseases].
|
Arch Monaldi Mal Torace
|
1993
|
0.75
|
|
16
|
[Haemocoagulative modifications correlated with pregnancy].
|
Minerva Ginecol
|
2006
|
0.75
|
|
17
|
A hypercoagulable state in activated protein C resistant patients with ischemic stroke.
|
Int J Clin Lab Res
|
1998
|
0.75
|
|
18
|
Subcortical ischaemic changes in young hypertensive patients: frequency, effect on cognitive performance and relationship with markers of endothelial and haemostatic activation.
|
Eur J Neurol
|
2007
|
0.75
|
|
19
|
[Hypersensitivity to oral anticoagulants: report of a case].
|
Ital Heart J Suppl
|
2001
|
0.75
|
|
20
|
High prevalence of activated protein C resistance in patients with systemic sclerosis.
|
Int J Clin Lab Res
|
1995
|
0.75
|
|
21
|
Regenerated EDL muscle of rats requires innervation to maintain AChE molecular forms.
|
Muscle Nerve
|
1990
|
0.75
|
|
22
|
Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control.
|
Thromb Haemost
|
1999
|
0.75
|
|
23
|
[Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
|
Minerva Ginecol
|
2004
|
0.75
|
|
24
|
Evaluation of genotyping methods and costs for VDR polymorphisms.
|
Eur Rev Med Pharmacol Sci
|
2017
|
0.75
|
|
25
|
[The effects of phytoestrogen therapy on the endometrium in postmenopausal women].
|
Minerva Ginecol
|
2005
|
0.75
|
|
26
|
Coagulation derangements in oral and maxillofacial surgery in patients with a documented cancer: a follow-up study after surgery.
|
J Dent Res
|
2003
|
0.75
|
|
27
|
[Hypercoagulability during pregnancy: evidences for a thrombophilic state].
|
Minerva Ginecol
|
2006
|
0.75
|
|
28
|
Analysis of three genetic polymorphisms as risk factors for thrombosis.
|
Int J Clin Lab Res
|
1999
|
0.75
|
|
29
|
[Diagnostic contribution of serum levels of tumor markers in adenocarcinoma of the breast].
|
J Nucl Med Allied Sci
|
1991
|
0.75
|
|
30
|
[The CA 19-9, CA 125, CA 72-4 and CA 50 tumor markers in neoplastic disease: results of a 3-year experience].
|
J Nucl Med Allied Sci
|
1991
|
0.75
|
|
31
|
Reversible adult respiratory distress in primary antiphospholipid syndrome.
|
Haematologica
|
2000
|
0.75
|